NCT07323004

Brief Summary

On the one hand, it helps to understand the motor development of preschool children, so as to provide early intervention means for the prevention of motor retardation and promote the healthy development of preschool children, and on the other hand, different motor intervention strategies are formulated according to the developmental characteristics of children with different core symptoms. It is of great academic value to verify the effectiveness of the program through empirical research on exercise intervention and promote the improvement of motor and cognitive development of children with neurodevelopmental disorders.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
13mo left

Started Jan 2026

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress20%
Jan 2026Jun 2027

First Submitted

Initial submission to the registry

April 11, 2025

Completed
9 months until next milestone

First Posted

Study publicly available on registry

January 7, 2026

Completed
23 days until next milestone

Study Start

First participant enrolled

January 30, 2026

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2026

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2027

Last Updated

January 7, 2026

Status Verified

December 1, 2025

Enrollment Period

4 months

First QC Date

April 11, 2025

Last Update Submit

December 30, 2025

Conditions

Outcome Measures

Primary Outcomes (7)

  • Change in Gross Motor Development

    Assessed using the Test of Gross Motor Development-3 (TGMD-3), which evaluates locomotor and object control skills.The scoring ranges from the lowest score of 0 to the highest score of 104 points, and the higher the score, the better the level of motor development.

    Baseline, Week 6 (midpoint), and Week 12 (post-intervention)

  • Change in Motor Coordination

    Evaluated with the Movement Assessment Battery for Children-Second Edition (MABC-2), which measures manual dexterity, aiming and catching, and balance skills.

    Baseline, Week 6, and Week 12

  • Change in Health-Related Physical Fitness

    Standing long jump (centimeters)

    Baseline, Week 6, and Week 12

  • Change in Health-Related Physical Fitness

    Continuous two-foot jump (times)

    Baseline, Week 6, and Week 12

  • Change in Health-Related Physical Fitness

    10m shuttle run (seconds)

    Baseline, Week 6, and Week 12

  • Change in Health-Related Physical Fitness

    Balance Beam Walk

    Baseline, Week 6, and Week 12

  • Change in Gross Motor Development

    Assessed using the Test of Gross Motor Development-3 (TGMD-3), which evaluates locomotor and object control skills.

    Baseline, Week 6 (midpoint), and Week 12 (post-intervention)

Secondary Outcomes (15)

  • Change in gait velocity (single task condition)

    Baseline and Week 12

  • Change in step size (single-task condition)

    Baseline and Week 12

  • Change in Gait Parameters and Dual-Task Cost

    Baseline and Week 12

  • Change in Working Memory

    Baseline and Week 12

  • Change in SDNN

    Baseline and Week 12

  • +10 more secondary outcomes

Study Arms (3)

typical development

NO INTERVENTION

This group consists of typically developing children aged 4-12 years. No intervention will be applied. The group will be used as a baseline for comparison and analysis of motor development and related health fitness indicators.

Special Intervention Group

EXPERIMENTAL

This group includes children aged 4-12 years diagnosed with neurodevelopmental disorders. Participants will receive a combined intervention consisting of traditional rehabilitation therapy and a structured, characteristic exercise program designed to improve motor development and core health-related fitness.

Behavioral: Characteristic Exercise Intervention

General Intervention Group

ACTIVE COMPARATOR

This group includes children aged 4-12 years diagnosed with neurodevelopmental disorders. Participants will receive standard traditional rehabilitation therapy without the additional characteristic exercise intervention.

Behavioral: Traditional Rehabilitation

Interventions

This intervention combines traditional rehabilitation techniques (e.g., occupational therapy and physical therapy focusing on fine and gross motor skills) with a structured, age-appropriate characteristic exercise program. The program includes dynamic balance training, sensory-motor integration activities, rhythmic movement games, and core stability exercises. * Frequency: 3 sessions per week * Duration: 45 minutes per session * Total Intervention Period: 12 weeks * Distinguishing Feature: The inclusion of customized play-based movement training and sensory-motor games designed specifically to support neurodevelopmental improvement in young children with motor delays.

Special Intervention Group

Participants will receive conventional rehabilitation therapy, including basic motor skill exercises, postural control training, and therapist-led occupational therapy sessions aimed at improving daily motor function. * Frequency: 3 sessions per week * Duration: 45 minutes per session * Total Intervention Period: 12 weeks * Distinguishing Feature: This group receives only traditional rehabilitation techniques without any additional structured or characteristic physical activity component.

General Intervention Group

Eligibility Criteria

Age4 Years - 12 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Children aged 4 to 12 years
  • Born at full term (gestational age ≥ 37 weeks and \< 42 weeks)
  • Provided informed consent signed by their legal guardian
  • For the ADHD group:
  • Diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD) by a qualified physician (e.g., child psychiatrist or psychologist) according to DSM-5 diagnostic criteria
  • For the typical development (control) group:
  • No symptoms related to ADHD (e.g., inattention, hyperactivity, impulsivity)
  • Normal scores on parent- and teacher-rated behavioral questionnaires (e.g., CBCL, SDQ)
  • No history of neurological or psychiatric disorders

You may not qualify if:

  • Diagnosis of other neurodevelopmental disorders, such as:
  • Autism Spectrum Disorder (ASD)
  • Learning disabilities
  • Epilepsy, cerebral palsy, or other neurological conditions
  • Developmental quotient (DQ) \< 85, as measured by standardized tools (e.g., Gesell scale)
  • Significant visual or hearing impairments, or congenital malformations
  • History of high-risk birth events, including but not limited to:
  • Severe birth asphyxia
  • Intrauterine infections
  • Presence of genetic or metabolic disorders, or severe dysfunction of vital organs
  • For the ADHD group: comorbid psychiatric conditions (e.g., schizophrenia, severe mood disorders)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

China Institute of Sport Science

Beijing, 100061, China

Location

MeSH Terms

Conditions

Neurodevelopmental Disorders

Condition Hierarchy (Ancestors)

Mental Disorders

Central Study Contacts

yanfeng zhang, Ph. D

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 11, 2025

First Posted

January 7, 2026

Study Start

January 30, 2026

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

June 1, 2027

Last Updated

January 7, 2026

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations